AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Quanterix Faces Financial Challenges Amid New Bylaws Adoption and Acquisition of Akoya Biosciences
ByAinvest
Friday, Aug 8, 2025 9:51 am ET1min read
Quanterix reported a 29% revenue decrease and net loss of $30 million in Q2 2025. Despite this, the company highlighted growth in Alzheimer's Diagnostics revenues and strategic actions for long-term growth. The Board of Directors adopted new bylaws for majority voting in director elections. Quanterix expects to achieve cash flow breakeven in 2026 and exit 2025 with $120 million in cash. The stock has a Hold rating with an $8.00 price target.
Quanterix Corporation (NASDAQ: QTRX), a leader in ultra-sensitive biomarker detection, announced its financial results for the second quarter ended June 30, 2025. The company reported a 29% decrease in revenue, totaling $24.5 million, compared to $34.4 million in the prior year. Despite the revenue decline, Quanterix highlighted significant growth in Alzheimer's Diagnostics revenues and strategic actions to position the business for long-term growth.The company's net loss for the quarter was $30.0 million, compared to a net loss of $7.4 million in the prior year. The GAAP gross margin decreased to 46.2% from 64.7% in the prior year, while the adjusted gross margin (non-GAAP) was 41.8%, down from 58.6% in the prior year. Quanterix ended the quarter with $263.8 million in cash, cash equivalents, marketable securities, and restricted cash, representing a use of cash of approximately $5.7 million.
Quanterix's strategic initiatives included the completion of the acquisition of Akoya Biosciences, the launch of new Alzheimer’s research assays, and the approval of the UltraDx Plasma pTau-217 Assay Kit in China. The company expects to report revenues in a range of $130 to $135 million for 2025, including approximately two quarters of performance from Akoya. On a pro forma basis, Quanterix expects to generate between $165 and $170 million in revenue for 2025.
The Board of Directors adopted new bylaws for majority voting in director elections. Quanterix expects to achieve cash flow breakeven in 2026 and exit 2025 with approximately $120 million in cash and cash equivalents. The stock has a Hold rating with an $8.00 price target.
References:
[1] https://finance.yahoo.com/news/quanterix-releases-financial-results-second-200600409.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet